Editor’s Note: Patient Worthy is honored to present this article, shared with us by our friends at the Steatotic Liver Foundation (formerly the Fatty Liver Foundation). To see this article in its original format, please click here.
If you have fatty liver disease, there’s a very good chance you’re also dealing with metabolic syndrome or type 2 diabetes. They travel together. The insulin resistance that drives MASLD is the same insulin resistance that drives type 2 diabetes.
So when I tell you that coffee appears to really reduce the risk of developing type 2 diabetes, I’m not changing the subject. I’m talking about the same disease from a different angle.
- 33% lower diabetes risk — drinking six cups daily (Ding et al. 2014, over 1.1 million participants)
- Decaf works too — 30% lower risk with 4+ cups of decaf daily (EPIC-Germany study)
- Dual benefit for liver patients — the same compounds protect both your liver and your metabolism
Chlorogenic acids boost GLP-1 production, trigonelline inhibits intestinal glucose uptake, and magnesium improves insulin sensitivity. The mechanisms are multiple and complementary — and the dose-response pattern is clear across European, Asian, and American populations.
If you missed Part 2, catch up here.
